References
- LebrunTWilmotteJSchizoaffective disorder: its nosographic significanceActa Psychiatr Belg1993932202358036940
- LakeCRHurwitzNSchizoaffective disorders are psychotic mood disorders; there are no schizoaffective disordersPsych Res2006143255287
- Vollmer-LarsenAJacobsenTBHemmingsenRParnasJSchizoaffective disorder – the reliability of its clinical diagnostic useActa Psychiatr Scand200611340240716603031
- KolibášEČaplováTFleischerJŠpeciálna psychiatriaBratislavaVydavatel’stvo UK199665
- EbertMHLoosenPTNurcombeBCurrent Diagnosis and Treatment in PsychiatryUSALange Medical Books/McGraw Hill2000
- LipkovichIDeberdtWBuckleyPFPrediction of combined symptomatic and functional outcome in patients with schizophrenia and schizoaffective disorderNeurotherapeutics20063410
- SirisSGDepression in schizophrenia: perspective in the area of “Atypical” antipsychotic agentsAm J Psychiatry20001571379138910964850
- KarowASchnedlerDNaberDWhat would the patient choose? Subjective comparison of atypical and typical neurolepticsPharma-copsychiatry2006394751
- ClarkREBartelsSJMellmanTAPeacockWJRecent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policySchizophr Bull200228758412047024
- TurnerMSStewartDWReview of the evidence for the long term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychosesJ Psychopharmacol200620203717046985
- FlynnJGriegerTABenedekDMPharmacologic treatment of hospitalized patients with schizoaffective disorderPsych Serv2002539496
- VojtekováL’HalarisAPospíšilRMonoterapia versus kombinovaná liečba akútnej fázy depresívneho typu schizoafektívnej poruchyPsych Pro Praxi200242529
- DóciIKovářováMKovaničováMLiečba schizoafektívnej poruchy na Psychiatrickej klinike v Košiciach v roku 2002Psychiatrie20032Suppl2526
- KaySRFiszbainAOplerLAThe Positive and Negative Syndrome Scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
- AddingtonDAddingtonJSchisselBA depression rating scale for schizophrenicsSchizophr Res199032472512278986
- AddingtonDAddingtonJMaticka-TyndaleEJoyceJReliability and validity of a depression rating scale for schizophrenicsSchizophr Res199262012081571313
- GuyWECDEU Assessment for PsychopharmacologyRockvilleUS DHEW1976534537
- HeinrichDWHanlonTECarpenterWTJrThe quality of life scale: an instrument for rating the schizophrenic deficit syndromeSchizophr Bull1984103883986474101
- EndicottJSpitzerRLFleissJLCohenJThe global assessment scale: A procedure for measuring the overall severity of psychiatric disturbanceArch Gen Psychiatry197633767771
- HoganTPAwadAGEastwoodRA self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychol Med1983131771836133297
- RossCKStewardCASinacoreJMThe importance of patient preferences in the measurement of health care satisfactionMed Care199331113811498246642
- SimpsonGMAngusJWSA rating scale for extrapyramidal side effectsActa Psychiatr Scand1970212Suppl1119
- JanicakPGKeckPEDavisJMA double blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorderJ Clin Psycho-pharmacol200121360368
- LeuchtSPitschel-WalzGAbrahamDKisslingWEfficacy and extra-pyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trialsSchizophr Res19993551689988841
- MarderSRMeibachRCRisperidone in the treatment of schizophreniaAm J Psychiatry19941518258357514366
- HunterRHJoyCBKennedyEGilbodySMSongFRisperidone versus typical antipsychotic medication for schizophreniaCochrane Database Syst Rev20032CD00044012804396
- Müller-SiechenederFMüllerMJHillertASzegediAWetzelHBenkertORisperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeJ Clin Psychopharmacol1998181111209555596
- TempierRPawliukNInfluence of novel and conventional antipsychotic medication on subjective quality of lifeJ Psychiatr Neurosci200126131136
- TiihonenJWahlbeckKLönnqvistJKlaukkaTIonnidisJPAVolavkaJHaukkaJEffectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyBMJ200633322422916825203